Postsynaptic 5-HT1B receptors modulate electroshock-induced generalised seizures in rats

被引:23
作者
Stean, TO
Atkins, AR
Heidbreder, CA
Quinn, LP
Trail, BK
Upton, N
机构
[1] GlaxoSmithKline, Neurol & GI CEDD, Harlow CM19 5AW, Essex, England
[2] GlaxoSmithKline, Psychiat CEDD, Harlow CM19 5AW, Essex, England
[3] Glaxo SmithKline Pharmaceut, Psychiat CEDD, Verona, Italy
关键词
postsynaptic 5-HT1B receptors; electroshock; generalised seizures; rat; SKF; 99101; RU; 24969; SB-224289;
D O I
10.1038/sj.bjp.0706027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Although an important regulatory role for serotonin (5-HT) in seizure activation and propagation is well established, relatively little is known of the function of specific 5-HT receptor subtypes on seizure modulation. 2 The aim of the present study was to investigate the role of 5-HT1A, 1B and 1D receptors in modulating generalised seizures in the rat maximal electroshock seizure threshold (MEST) test. 3 The mixed 5-HT receptor agonists SKF 99101 (5-20 mg kg(-1) i.p.) and RU 24969 (1-5 mg kg(-1) i.p.), 0.5 h pretest, both produced marked dose-related increases in seizure threshold. These agents share high affinity for 5-HT1A, 1B and 1D receptors. 4 Antiseizure effects induced by submaximal doses of these agonists were maintained following p-chlorophenylalanine (150 mg kg(-1) i. p. x 3 days)-induced 5-HT depletion. 5 The anticonvulsant action of both SKF 99101 (15 mg kg(-1) i. p.) and RU 24969 (2.5 mg kg(-1) i.p.) was dose-dependently abolished by the selective 5-HT1B receptor antagonist SB-224289 (0.1-3 mg kg(-1) p.o., 3 h pretest) but was unaffected by the selective 5-HT1A receptor antagonist WAY 100635 (0.01-0.3 mg kg(-1) s.c., 1 h pretest). This indicates that 5-HT1B receptors are primarily involved in mediating the anticonvulsant properties of these agents. 6 In addition, the ability of the 5-HT1B/1D receptor antagonist GR 127935 (0.3-3 mg kg(-1) s.c., 60 min pretest) to dose-dependently inhibit SKF 99101-induced elevation of seizure threshold also suggests possible downstream involvement of 5-HT1D receptors in the action of this agonist, although confirmation awaits the identification of a selective 5-HT1D receptor antagonist. 7 Overall, these data demonstrate that stimulation of postsynaptic 5-HT1B receptors inhibits electroshock-induced seizure spread in rats.
引用
收藏
页码:628 / 635
页数:8
相关论文
共 38 条
[1]   How does pindolol improve antidepressant action? [J].
Artigas, F ;
Celada, P ;
Laruelle, M ;
Adell, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (05) :224-228
[2]  
BEHR J, 1996, PSYCH RES, V737, P1
[3]   REGIONAL CHANGES IN CEREBRAL GLUCOSE-UTILIZATION ASSOCIATED WITH AMYGDALOID KINDLING AND ELECTROSHOCK IN THE RAT [J].
BLACKWOOD, DHR ;
KAPOOR, V ;
MARTIN, MJ .
BRAIN RESEARCH, 1981, 224 (01) :204-208
[4]  
BURLEY ES, 1984, FED PROC, V43, P2521
[5]   NEUROPHARMACOLOGY OF 5-HYDROXYTRYPTAMINE(1B/D) RECEPTOR LIGANDS [J].
CHOPIN, P ;
MORET, C ;
BRILEY, M .
PHARMACOLOGY & THERAPEUTICS, 1994, 62 (03) :385-405
[6]   On the elevated plus maze the anxiolytic like effects of the 5-HT1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635 [J].
Collinson, N ;
Dawson, GR .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :35-43
[7]   Carbamazepine increases extracellular serotonin concentration: Lack of antagonism by tetrodotoxin or zero Ca2+ [J].
Dailey, JW ;
Reith, MEA ;
Yan, QS ;
Li, MY ;
Jobe, PC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 328 (2-3) :153-162
[8]  
DELEAN A, 1978, AM J PHYSIOL, V235, P97
[9]  
Fletcher A, 1996, BEHAV BRAIN RES, V73, P337
[10]   The selective 5-HT1B receptor inverse agonist 1′-methyl-5[[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo [J].
Gaster, LM ;
Blaney, FE ;
Davies, S ;
Duckworth, DM ;
Ham, P ;
Jenkins, S ;
Jennings, AJ ;
Joiner, GF ;
King, FD ;
Mulholland, KR ;
Wyman, PA ;
Hagan, JJ ;
Hatcher, J ;
Jones, BJ ;
Middlemiss, DN ;
Price, GW ;
Riley, G ;
Roberts, C ;
Routledge, C ;
Selkirk, J ;
Slade, PD .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (08) :1218-1235